A 72-year-old woman with heart failure (LVEF 35%) and hypertension is started on lisinopril and furosemide 40 mg daily. After 2 weeks, she develops severe muscle cramps, fatigue, and generalized weakness. Laboratory findings: Na⁺ 128 mEq/L, K⁺ 2.9 mEq/L, Cl⁻ 92 mEq/L, HCO₃⁻ 32 mEq/L. ECG shows U waves and flattened T waves. Which electrolyte abnormality is the primary driver of her symptoms, and what is the most appropriate next step?

Explanation

## Clinical Diagnosis This patient has **loop diuretic-induced hypokalemia** with **metabolic alkalosis** and **hyponatremia**. ### Electrolyte Pattern Analysis | Parameter | Value | Interpretation | | --- | --- | --- | | **K⁺** | 2.9 mEq/L | Severe hypokalemia (normal 3.5–5.0) | | **Na⁺** | 128 mEq/L | Mild hyponatremia (normal 135–145) | | **Cl⁻** | 92 mEq/L | Hypochloremia (normal 98–107) | | **HCO₃⁻** | 32 mEq/L | Metabolic alkalosis (normal 22–26) | **Key Point:** The **hypokalemia** is the primary culprit for her symptoms (muscle cramps, weakness, fatigue). The ECG changes (U waves, flattened T waves) are pathognomonic for hypokalemia and indicate risk of arrhythmias. ## Mechanism of Loop Diuretic-Induced Hypokalemia 1. **Increased distal Na⁺ delivery** → increased Na⁺ reabsorption in collecting duct 2. **Enhanced K⁺ secretion** in exchange for Na⁺ (principal cell mechanism) 3. **Metabolic alkalosis** (from Cl⁻ loss and volume contraction) → worsens K⁺ loss - Alkalosis shifts K⁺ intracellularly (H⁺ out, K⁺ in) → lower serum K⁺ 4. **Net result:** Severe hypokalemia + hypochloremic metabolic alkalosis ## Why Option 1 (Spironolactone) Is WRONG **Warning:** Adding spironolactone alone is **inappropriate** because: - The patient is already on **lisinopril** (ACE inhibitor) - ACE inhibitor + spironolactone = **high hyperkalemia risk** - Spironolactone takes **3–5 days** to reach full effect; acute hypokalemia needs urgent correction - The patient has **symptomatic hypokalemia with ECG changes** — needs faster intervention ## Correct Management: Option 2 **High-Yield:** In loop diuretic-induced hypokalemia, the best approach is: 1. **Immediate:** Potassium supplementation (KCl 20–40 mEq PO daily, or IV if severe/symptomatic) 2. **Concurrent:** Reduce furosemide dose if possible, or add a **potassium-sparing diuretic** (amiloride, triamterene) — NOT spironolactone in ACE inhibitor users 3. **Dietary:** Increase K⁺-rich foods (bananas, potatoes, spinach) 4. **Monitor:** Repeat K⁺, ECG in 24–48 hours **Clinical Pearl:** In heart failure, **amiloride** (ENaC blocker) is often preferred over spironolactone when the patient is already on an ACE inhibitor, because it has a faster onset and lower hyperkalemia risk if used cautiously. ## Why Other Options Fail | Option | Why Wrong | | --- | --- | | **Option 0 (Spironolactone alone)** | Slow onset (3–5 days); high hyperkalemia risk with lisinopril; doesn't address acute symptomatic hypokalemia. | | **Option 2 (Hyponatremia focus)** | Hyponatremia (128) is mild and secondary to volume depletion + diuretic use. The **hypokalemia is the primary symptomatic problem**. Fluid restriction may worsen K⁺ loss. | | **Option 3 (Acetazolamide)** | Acetazolamide causes **further K⁺ loss** and worsens hypokalemia. It is contraindicated in this scenario. | ## ECG Correlates of Hypokalemia **Mnemonic: U-FLAT** — U waves, Flattened T waves, Long QT, Arrhythmias, T wave inversion - **U waves** (small positive deflection after T wave) — most characteristic - **Flattened/inverted T waves** - **Prolonged QT interval** - **Risk:** Ventricular ectopy, torsades de pointes [cite:Harrison 21e Ch 276; KD Tripathi 8e Ch 18]